(Vienna, 23.11.2021) CONGRATS to Irfete Fetahu, PhD, postdoc at St. Anna CCRI on receiving a Stand-Alone Grant from the Austrian Science fund FWF. Together with her PI Sabine-Taschner-Mandl from the Tumor Biology group and colleagues, Irfete has the ambitious goal to decode the epigenome and its regulation in neuroblastoma, a…
New FWF-grant approved: Decoding the epigenome and its regulation in neuroblastoma
Somatic Sex - the development of malignant diseases reinterpreted
(Vienna, 28.10.2021) How do malignant diseases develop? In his recent publication, Oskar Haas from St. Anna Children's Cancer Research Institute suggests that the unique chromosome patterns, which define specific tumor types, arise from an accidental fusion of two normal cells - a process that simulates the fertilization of an egg…
"Rare diseases are also an emergency!"
(27.10.2021)"Rare diseases are also an emergency!" - That was the message from the European Reference Networks (ERNs) for rare diseases to members of the European Parliament at a joint meeting in Strasbourg. Currently, the EU spends a lot of money on combating the pandemics, which is undoubtedly a major priority.…
Sabine Taschner-Mandl is elected to the executive board of Europe’s neuroblastoma network SIOPEN
(Vienna, 20.10.2021) Developing new therapies for childhood nerve tumors and identifying more molecular markers for better diagnosis – this is what Sabine Taschner-Mandl strives for in her new role as Executive Committee Board Member of the European Neuroblastoma Research Group SIOPEN. Sabine Taschner-Mandl, PhD, head of the Tumor Biology Research…
BOKU Talent and Best Paper Award for Charlotte Zajc!
(Vienna, 14.10.2021) CONGRATULATIONS to Charlotte Zajc, PhD, who is honored twice! The scientist from our Christian Doppler (CD) Laboratory for Next Generation CAR T cells receives the BOKU Talent Award and the BOKU Best Paper Award from the City of Vienna Jubilee Funds. During her PhD studies, Charlotte Zajc designed…
EU Commissioner visits St. Anna: "Europe’s Beating Cancer Plan puts the spotlight on childhood cancer"
(Vienna, 08.09.2021) Childhood cancer is different from cancer in adults. Thus, it needs research specifically tailored to pediatric tumors, which requires dedicated funding. The need for medicines suitable for children, as well as improvements in long-term follow-up care for cancer survivors have been discussed with EU Health Commissioner Stella Kyriakides,…
St. Anna scientist honored twice
(Salzburg, 02.10.21) ÖGKJ honors and awards Prof. Ruth Ladenstein, MD: The pediatric cancer researcher and physician receives not only the Clemens von Pirquet Award but also a prize for the best oncological publication. Every year, the Austrian Society for Pediatrics and Adolescent Medicine (ÖGKJ) honors its members for outstanding scientific…
Benjamin Salzer and Charlotte Zajc win Life Science Research Awards
(Vienna, 20.09.2021) CONGRATULATIONS to Benjamin Salzer, PhD, and Charlotte Zajc, PhD, from our Christian Doppler Laboratory for Next Generation CAR T Cells! Both have won with their publication resulting from their doctoral thesis a first place at the Life Science Research Awards Austria 2021 – Benjamin Salzer (St. Anna Children's…
Kaan Boztug awarded the "Işil Berat Barlan Award for Primary Immunodeficiency Diseases"
(Vienna, 03.09.2021) Congratulations! Assoc.-Prof. Kaan Boztug, MD, Scientific Director of the St. Anna Children's Cancer Research Institute and Director of the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, has been awarded the Işil Berat Barlan Award for his outstanding research in the field of primary immunodeficiencies, which will be…
Bone marrow metastases for the first time analyzed cell by cell
(02.09.2021) When childhood nerve tumors, so-called neuroblastomas, form metastases, they preferentially do so in the bone marrow. A study by St. Anna Children's Cancer Research Institute shows for the first time the exact cell composition of such metastases. This knowledge forms the basis for the development of therapy concepts that…